QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=DE304EC9CDF11B7124964268841F1366;jsessionid=C57F5F3FC8F419FF7AD96B2ECA778D7B;jsessionid=63E01C4BBFBC2432E9D7710EEDDC51F5;jsessionid=1CC3BC34D4EF01B339AF6B3613099F8D;jsessionid=0D0CBDDB7429443D57CF8E2D9B40B3B1;jsessionid=08C2A92BB2F29C0A0A8410F4D2F0D603;jsessionid=07E5F86604BBB3B061CD2F2E57081EB3 (gene)

1. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
2. Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggre…
3. The RNA-binding protein and stress granule component ATAXIN-2 is expressed in mouse and human tissue…
4. Ataxin-2 gene: a powerful modulator of neurological disorders.
5. Antagonistic roles for Ataxin-2 structured and disordered domains in RNP condensation.

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=DE304EC9CDF11B7124964268841F1366;jsessionid=C57F5F3FC8F419FF7AD96B2ECA778D7B;jsessionid=63E01C4BBFBC2432E9D7710EEDDC51F5;jsessionid=1CC3BC34D4EF01B339AF6B3613099F8D;jsessionid=0D0CBDDB7429443D57CF8E2D9B40B3B1;jsessionid=08C2A92BB2F29C0A0A8410F4D2F0D603;jsessionid=07E5F86604BBB3B061CD2F2E57081EB3